Our Services
We provide a comprehensive array of financial services to a diverse range of corporate clients, institutional investors, and high net worth investors.
Investment Banking
Equity Research
Capital Markets
Merchant Capital
Wealth Management
Prime Brokerage
Recent
Transactions
Over 180 financings and $23.5 Billion in aggregate as Lead, Joint, or Co-Manager in 2021
$15.0 Million
Registered Direct Offering
// Sole Placement Agent
August 2022
$13.5 Million
Initial Public Offering
// Lead Book-Running Manager
August 2022
$5.0 Million
PIPE
// Sole Placement Agent
August 2022
$3.3 Million
Follow-On Offering & Uplisting to NASDAQ
// Sole Book-Running Manager
August 2022
$18.0 Million
Follow-On Offering
// Co-Placement Agent
August 2022
$3.4 Million
CMPO
// Sole Book-Running Manager
August 2022
$3.9 Million
Follow-On Offering and Uplisting to NASDAQ
// Sole Book-Running Manager
August 2022
$5.95 Million
Registered Direct Offering
// Sole Placement Agent
July 2022
$26.0 Million
Follow-On Offering
// Sole Placement Agent
July 2022
$20.3 Million
Initial Public Offering
// Joint Book Runner
July 2022
$10.0 Million
PIPE
// Sole Placement Agent
July 2022
Upcoming Events
Maxim Group events are hosted on our digital platform, M-Vest
There are no upcoming events at this time
![Maxim_Merchant-Capital_logo-01[1]](https://www.maximgrp.com/wp-content/uploads/2020/02/Maxim_Merchant-Capital_logo-011.svg "Maxim_Merchant-Capital_logo-01[1]"){kind=logo}
Merchant Capital
Maxim Merchant Capital’s skilled specialists have significant experience in raising private capital for both late-stage and early-stage private and public companies across a range of industries; predominantly in life sciences/biotechnology. Within the biotech sector, we look for companies that address significant unmet needs and have a clear regulatory path.
